statistiche ricercatore

TOSI, GIOVANNA

Distribuzione geografica

Continente	#
NA - Nord America	7.780
EU - Europa	6.046
AS - Asia	1.621
Continente sconosciuto - Info sul continente non disponibili	8
AF - Africa	2
SA - Sud America	2
Totale	15.459

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	7.701
IT - Italia	2.445
UA - Ucraina	1.553
TR - Turchia	637
VN - Vietnam	582
SE - Svezia	559
DE - Germania	486
CN - Cina	397
FI - Finlandia	394
IE - Irlanda	236
GB - Regno Unito	132
FR - Francia	106
CA - Canada	79
BE - Belgio	70
RU - Federazione Russa	40
EU - Europa	8
NL - Olanda	7
CH - Svizzera	3
BY - Bielorussia	2
HR - Croazia	2
RS - Serbia	2
AT - Austria	1
BR - Brasile	1
CZ - Repubblica Ceca	1
DK - Danimarca	1
DZ - Algeria	1
EG - Egitto	1
ES - Italia	1
GR - Grecia	1
IL - Israele	1
JP - Giappone	1
ME - Montenegro	1
MK - Macedonia	1
NO - Norvegia	1
PH - Filippine	1
PL - Polonia	1
SG - Singapore	1
TW - Taiwan	1
VE - Venezuela	1
Totale	15.459

Salva come PNG Salva come JPEG

Città	#
Milan	2.132
Jacksonville	1.191
Fairfield	928
Chandler	783
Woodbridge	609
Wilmington	428
Ann Arbor	424
Izmir	405
Princeton	398
Houston	386
Seattle	369
Dearborn	366
Ashburn	343
Nyköping	297
Cambridge	287
Dong Ket	268
Dublin	236
Beijing	167
San Mateo	138
Rome	120
Como	91
San Diego	76
Toronto	76
Brussels	69
Düsseldorf	45
Hefei	34
Verona	33
Boardman	31
Nanjing	28
Norwalk	25
Helsinki	23
Kunming	19
London	19
Falls Church	17
Guangzhou	15
Jinan	15
Phoenix	13
Fuzhou	11
Kocaeli	9
Hanover	8
Nanchang	8
Hangzhou	7
Hebei	7
Xian	7
Auburn Hills	6
Changsha	6
Wuhan	6
Chongqing	5
Edinburgh	5
Perugia	5
Ponte Lambro	5
Chengdu	4
Indiana	4
Shenyang	4
Zhengzhou	4
Aprilia	3
Baotou	3
Chiswick	3
Costa Mesa	3
Islington	3
Lausanne	3
Los Angeles	3
Monza	3
New York	3
Quzhou	3
Redmond	3
San Francisco	3
Ürümqi	3
Amsterdam	2
Belgrade	2
Boydton	2
Fiesole	2
Guiyang	2
Huzhou	2
Jinhua	2
Leawood	2
Mariano Comense	2
Minsk	2
Montreal	2
Rozzano	2
Shaoxing	2
Stanford	2
Taiyuan	2
Wenzhou	2
Wilnsdorf	2
Zagreb	2
Algiers	1
Asti	1
Belo Horizonte	1
Berlin	1
Biella	1
Birmingham	1
Bologna	1
Cernusco Sul Naviglio	1
Changchun	1
Chaoyang	1
Chicago	1
Copenhagen	1
Cormeilles-en-Parisis	1
Cutrofiano	1
Totale	11.104

Salva come PNG Salva come JPEG

Nome	#
Tripartite Motif-Containing Protein 22 Interacts with Class II Transactivator and Orchestrates Its Recruitment in Nuclear Bodies Containing TRIM19/PML and Cyclin T1	166
CIITA-driven MHC class ii expressing tumor cells can efficiently prime naive CD4+ TH cells in vivo and vaccinate the host against parental MHC-II-negative tumor cells	165
Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)	155
The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells	152
Localization, quantification and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL	150
Boosting the MHC class II-restricted tumor antigen presentation to CD4+ T helper cells: A critical issue for triggering protective immunity and re-orienting the tumor microenvironment toward an anti-tumor state	147
Picosecond-resolved FRET on non-amplified DNA for identifying individuals genetically susceptible to type-1 diabetes	146
The MHC class II transactivator: prey and hunter in infectious diseases	142
Cell lineage-specific and developmental stage-specific controls of MHC class-II-antigen expression.	134
The MHC-II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation	133
The MHC Class II transactivator CIITA inhibits the persistent activation of NF-kB by Tax-1	133
Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson's disease pathogenesis	132
Typing of a polymorphic human gene conferring susceptibility to insulin-dependent diabetes mellitus by picosecond-resolved FRET on non-purified/non-amplified genomic DNA	129
The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators	127
Localization, quantization and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL	126
Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells	124
A girl with Diabetes and severe Combined Immunodeficiency from Adenosine Deaminase Deficiency	124
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection and specific anti-tumor memory.	122
Molecular and cellular correlates of the CIITA-mediated inhibition of HTLV-2 Tax-2 transactivator function resulting in loss of viral replication	122
Neonatal Fc receptor is involved in the protection of fibrinogen after its intake in peripheral blood mononuclear cells	122
The MHC class II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation.	121
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific anti-tumor memory	118
Distinct regulation of HLA class II and class I cell surface expression in THP-1 macrophage cell line after bacterial phagocytosis	115
The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication	114
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a TH1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory	114
Adequate Antigen Availability: A Key Issue for Novel Approaches to Tumor Vaccination and Tumor Immunotherapy	114
HLA-DQ genotype in early onset insulin dependent diabetes mellitus	113
MHC class II gene regulation: some historical considerations on a still ontogenetic and phylogenetic puzzle	112
Assessment of the DQB1-DQA1 complete genotype allows best prediction for IDDM	112
MHC class II transactivator CIITA inhibits Tax-2-mediated HTLV-2 LTR transactivation and viral replication by binding to and affecting Tax-2 intracellular localization	112
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic virus type 1.	110
The MHC-II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation	110
New approaches of cancer vaccination and cancer immunotherapy based on the optimal stimulation of tumor-specific, MHC class II-restricted CD4+ T helper cells	110
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma	110
Highly stable oligomerization forms of HIV-1 Tat detected by monoclonal antibodies and requirement of monomeric forms for the transactivating function on the HIV-1 LTR	108
Major histocompatibility complex class II transcriptional platform: assembly of nuclear factor Y and regulatory factor X (RFX) on DNA requires RFX5 dimers	108
Phosphorylation of CIITA directs its oligomerization, accumulation and increased activity on MHCII promoters	108
Insight into the molecular mechanism of CIITA-mediated inhibition of HIV-1 and HTLV transactivators	108
HIV-1 Tat mutants in the cysteine-rich region down-regulate HLA class II expression in T lymphocytic and macrophage cell lines	107
The MHC-II transactivator CIITA inhibits Tat-mediated HIV-1 LTR transactivation and virus replication in human U937 monocytic cells	106
Role of the HLA-DQ genotype in IDDM susceptibility	106
Tumor Immunology meets Immunology: Modified cancer cells as professional APC for priming naÃ¯ve tumor-specific CD4+ T cells	106
Fowlpoxvirus recombinants coding for the CIITA gene increase the expression of endogenous MHC-II and Fowlpox Gag/Pro and Env SIV transgenes	106
MHC class II enhanceosome: how is the class II transactivator recruited to DNA-bound activators?	105
The complex interplay of the DQB1 and DQA1 loci in the generation of the susceptible and protective phenotype for Insulin-Dependent Diabetes Mellitus	104
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic virus type 1	103
Molecular and Cellular Correlates of the CIITA-Mediated Inhibition of HTLV-2 Tax-2 Transactivator Function Resulting in Loss of Viral Replication.	103
Expression of MHC class I and class II antigens in pancreatic adenocarcinomas	99
The MHC Class II transactivator, CIITA,is a viral restriction factor for human oncogenic retroviruses	99
HTLV-2 Tax-2 transactivator increases the expression and the function of its inhibitor CIITA, the master regulator of HLA-II gene transcription	98
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic Virus Type 1	98
Tax-1-mediated HTLV-1 replication and NF-kB activation is inhibited by the MHC-II transactivator CIITA	97
The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-kappa B by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein	97
The MHC class II transactivator CIITA inhibits the persistent activation of NF-kB by Human T cell Lymphotropic Virus type-1 Tax-1 oncoprotein	97
Inhibition of Human T-Cell Leukemia virus type 2 (HTLV-2) replication by the suppressive action of CIITA and NF-Y	96
HLA-DQB1 typing of north east italian IDDM patients using amplified DNA, oligonucleotide probes and a rapid DNA-Enzyme Immunoassay (DEIA)	96
Transient internalization and/or block of export to the cell surface of HLA Class II and CD1b molecules after bacterial phagocytosis	95
The MHC-II transactivator CIITA is a viral restriction factor against HIV-1 replication	95
Molecular typing of polymorphic genes by time-resolved fluorescence resonance energy transfer	94
Optimal MHC-II-restricted tumor antigen presentation to CD4+ T helper cells: the key issue for development of anti-tumor vaccines	94
Tax-1-mediated NF-kB activation is inhibited by the MHC-II transactivator CIITA	94
Tat protein is an HIV-1 encoded SS-chemochine homolog that promotes migrationand upregulates CCR3 on human FceRI+ cells	90
Autoimmunità e Malattie Autoimmuni	90
Time-Resolved Förster Resonance Energy Transfer Analysis of Single-Nucleotide Polymorphisms: Towards Molecular Typing of Genes on Non-Purified and Non-PCR-Amplified DNA	89
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic Virus Type 1	88
Adequate Antigen Availability (AAA) in antitumor immunity: Definition and consequences for novel strategies of tumor prevention and antitumor treatment	88
Human T-cell leukemia virus type II directly acts on CD34+ hematopoietic precursors by increasing their survival potential. Envelope associated HLA class II molecules reverse this effect	87
Tumor treatment by TNF-alpha targeted to tumor vessels and melphalan induces strong adaptive immune response, protection from tumor growth and anti-tumor memory.	85
Transient internalization and/or block of export to the cell surface of HLA Class II and CD1B molecules after mycobacterial phagocytosis	84
CIITA dependent MHC class II IA expression in tumor cells triggers CD4 T cell protective and long lasting antitumor immunity	84
The constitutive activation of NF-kB by HTLV-1 Tax-1 oncoprotein is inhibited by the MHC class II transactivator CIITA	83
A new strategy of tumor vaccination based on mammary adenocarcinoma cells transduced with the MHC class II transactivator CIITA	81
Apparente dissociazione tra fenotipo DR e genotipo MHC di classe II in IDDM	80
The MHC class II transactivator (CIITA): a "physiologic" drug against HIV-1 replication	80
Therapy-induced antitumor vaccination by targeting TNFa to tumor vessels in combination with melphalan	79
Associazione tra genotipo HLA-DQ e suscettibilità al Diabete insulino-Dipendente	79
A dual defensive role of CIITA against retroviral infections	79
Control of mammary adenocarcinoma growth in vivo by gene therapy with the MHC class II transactivator CIITA	76
Evidence for a specific post- transcriptional mechanism controlling the expression of HLA-DQ, but not DR and DP molecules	76
Host-retrovirus interaction: role of CIITA in the inhibition of HTLV-1 replication and oncogenic potential	76
TPA-mediated down-regulation of MHC class II gene expression in human macrophage precursors by destabilization of the MHC-II transactivator (CIITA) mRNA	74
Regulation of HLA antigen expression in HIV infected cells	73
HTLV-II Tax-2 increases the cell surface expression of HLA-II molecules by acting at the level of CIITA, the master regulator of HLA-II transcription	72
Reduced expression of the AIR-1 gene product CIITA as the cause of HLA class II down-modulation in normal human macrophages during bacterial phagocytosis	71
The HLA class II transcriptional activator (CIITA) blocks the function of HIV-1 Tat and inhibits viral replication	71
Tumor vaccination by CIITA-mediated MHC-II-expressing neoplastic cells	70
Therapy-induced antitumor vaccination by targeting tumor necrosis factor alpha to tumor vessels in combination with melphalan	70
Espressione delle molecole HLA di classe II in cellule di epatocarcinoma classe II negative dopo trasfezione del transattivatore CIITA. Acquisizione della capacità di processare e presentare l'antigene	70
The MHC class II transactivator, CIITA, blocks the transcriptional activity of both HTLV-2 Tax-2 and HTLV-1 Tax-1	69
Complete HLA-DQ genotyping better defines IDDM susceptibility	69
HTLV-II è mitogenico per i precursori emopoietici CD34+. La presenza di molecole HLA di classe II sull'envelope virale annulla tale effetto	68
CIITA reduced transcription as the cause of HLA class II down-modulation in human macrophages during bacterial phagocytosis	68
The MHC class II transactivator (CIITA): a physiologic inhibitor of HIV1 and HTLV2 retroviral infections	68
HLA-DQ typing for prediction of IDDM? Some "yes" people.	68
Efficient antigen presentation and T cell activation by MHC class II molecules of CIITA-transfected epatocarcinoma cells	67
CIITA blocks the function of HIV-1 Tat by competing for cyclin T1 and inhibits viral replication	67
CIITA, the Master Regulator of MHC Class II Gene Transcription, Targets the Viral Transactivator Tax-1 to Inhibit HTLV-I Viral Replication and NFKB Activation	67
Cellular and molecular aspects of immune response relevant to autoimmune diseases	67
Inhibition of human T cell leukemia virus type 2 (HTLV-2) replication by the suppressive action of class II transactivator and nuclear factor Y	66
The MHC class II transactivator CIITA blocks the replication of human oncogenic retroviruses	66
Totale	10.018

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	38.817
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	38.817

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2018/2019	1.812	0	0	558	5	9	14	26	201	2	108	294	595
2019/2020	2.964	118	72	117	502	156	340	476	400	211	292	44	236
2020/2021	2.667	28	282	81	265	62	272	83	287	431	102	242	532
2021/2022	1.700	211	223	152	133	42	48	57	123	83	222	159	247
2022/2023	2.208	252	86	120	258	159	493	12	302	315	78	76	57
2023/2024	2.382	820	812	750	0	0	0	0	0	0	0	0	0
Totale													15.525